Targeted metabolomic profiling of gastric cancer biopsies
The Indian Journal of Medical Research · 10.03.2026 · 163 · 710-719
DOI: 10.25259/ijmr_3386_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 10.03.2026. Verfasst von Aathithya Rangarajan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Stomach Neoplasms, Metabolomics, Metabolome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and objectives Gastric cancer, the fifth most diagnosed malignancy worldwide and seventh in India, exhibits high metabolic activity and marked heterogeneity. In this study, we performed targeted metabolomic profiling of gastric cancer biopsies obtained through esophagogastroduodenoscopy in a South Indian cohort.
Methods
Targeted metabolite profiling was conducted using liquid chromatography–mass spectrometry (LC–MS) analysis. Pathway enrichment and biomarker evaluation were performed using MetaboAnalyst 6.0, incorporating univariate analysis and receiver operating characteristic (ROC) curve assessment.
Results
LC-MS based analysis of tumour (n=25), paired normal (n=25), and normal gastric mucosa (n=3) samples revealed distinct metabolic alterations associated with gastric cancer. The metabolic profiles of tumours and paired normal tissues were similar when compared with normal mucosa, suggesting a potential field effect in gastric carcinogenesis. A total of 58 metabolites were identified, of which 44.8% comprising peptides, amino acids, and their derivatives showed marked upregulation in tumours, indicating enhanced amino acid metabolism. Elevated uracil and uridine levels suggested altered pyrimidine metabolism, reflecting increased nucleotide turnover and supporting rapid DNA/RNA synthesis. Pathway analysis highlighted modulation of arginine biosynthesis, serine–one carbon metabolism, and nucleotide metabolism in gastric cancer tissues. ROC analysis identified ornithine and citrulline as potential discriminators in gastric cancer. Interpretation and conclusions Our findings reveal differentially altered metabolites in gastric cancer that are predominantly involved in arginine, serine one-carbon, and nucleotide metabolism. Ornithine and citrulline were identified as potential diagnostic biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
- Department of Medical Gastroenterology, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
- Department of Oncopathology, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
Zitieren
APA
Rangarajan, A., Natarajan, T., Lakshminarayanan, S., Sundersingh, S., Subramani, J., & Gopisetty, G. (2026). Targeted metabolomic profiling of gastric cancer biopsies. The Indian Journal of Medical Research, 163, 710-719. https://doi.org/10.25259/ijmr_3386_2025
Vancouver
Rangarajan A, Natarajan T, Lakshminarayanan S, Sundersingh S, Subramani J, Gopisetty G. Targeted metabolomic profiling of gastric cancer biopsies. The Indian Journal of Medical Research. 2026;163:710-719. doi:10.25259/ijmr_3386_2025
BibTeX
@article{Rangarajan2026,
author = {Rangarajan, Aathithya and Natarajan, Thirumoorthi and Lakshminarayanan, Sujatha and Sundersingh, Shirley and Subramani, Jayavelu and Gopisetty, Gopal},
title = {Targeted metabolomic profiling of gastric cancer biopsies},
journal = {The Indian Journal of Medical Research},
year = {2026},
volume = {163},
pages = {710--719},
doi = {10.25259/ijmr_3386_2025}
}
EUVIMED